On the Radar 315 20 March 2017 On the Radar is a summary of some of the recent publications in the areas of safety and quality in health care. Inclusion in this document is not an endorsement or recommendation of any publication or provider. Access to particular documents may depend on whether they are Open Access or not, and/or your individual or institutional access to subscription sites/services. Material that may require subscription is included as it is considered relevant. On the is available online, via email or as a PDF or Word document from If you would like to receive On the Radar via email, you can subscribe on our website or by emailing us at H. You can also send feedback and comments to H. For information about the Commission and its programs and publications, please visit You can also follow us on Twitter @ACSQHC. On the Editor: Dr Niall Johnson Contributors: Niall Johnson, Alice Bhasale Reports The Economics of Patient Safety : Strengthening a value-based approach to reducing patient harm at national level Slawomiriski L, Auraaen A, Klazinga N OECD Publishing; 2017. p. 65. URL This OECD-authored report was prepared for a workshop at the Second Global Ministerial Summit on Patient Safety to be held in Germany this month. The report focuses on the economics of patient safety and has two major sections: The cost of failure. Estimating the costs of lapses in patient safety. Reducing harm effectively and efficiently. Exploring a value-based approach to investing in patient safety in a resource-constrained context. The relative costs and impact of various interventions (and combinations thereof) targeting patient harm across healthcare systems are estimated using a snapshot survey of international patient safety experts and policy makers. The key messages from this report include: Notes Patient safety is a critical policy Patient harm is estimated to be the 14th leading cause of the global disease burden. The cost to patients, healthcare systems and societies is considerable. Patient harm imparts a high financial cost. Overall, the available evidence suggests that 15% of hospital expenditure and activity in OECD countries can be attributed to treating safety failures. Patient harm is felt in the broader economy through lost capacity and productivity of patients and carers. It is estimated that the aggregate costs amount to trillions of dollars each year. Most of the burden is associated with a few common adverse events. The most burdensome include healthcare-associated infections (HAI), venous
On the Radar 315 20 March 2017 On the Radar is a summary of some of the recent publications in the areas of safety and quality in health care. Inclusion in this document is not an endorsement or recommendation of any publication or provider. Access to particular documents may depend on whether they are Open Access or not, and/or your individual or institutional access to subscription sites/services. Material that may require subscription is included as it is considered relevant. On the is available online, via email or as a PDF or Word document from If you would like to receive On the Radar via email, you can subscribe on our website or by emailing us at H. You can also send feedback and comments to H. For information about the Commission and its programs and publications, please visit You can also follow us on Twitter @ACSQHC. On the Editor: Dr Niall Johnson Contributors: Niall Johnson, Alice Bhasale Reports The Economics of Patient Safety : Strengthening a value-based approach to reducing patient harm at national level Slawomiriski L, Auraaen A, Klazinga N OECD Publishing; 2017. p. 65. URL Notes This OECD-authored report was prepared for a workshop at the Second Global Ministerial Summit on Patient Safety to be held in Germany this month. The report focuses on the economics of patient safety and has two major sections: The cost of failure. Estimating the costs of lapses in patient safety. Reducing harm effectively and efficiently. Exploring a value-based approach to investing in patient safety in a resource-constrained context. The relative costs and impact of various interventions (and combinations thereof) targeting patient harm across healthcare systems are estimated using a snapshot survey of international patient safety experts and policy makers. The key messages from this report include: Patient safety is a critical policy Patient harm is estimated to be the 14th leading cause of the global disease burden. The cost to patients, healthcare systems and societies is considerable. Patient harm imparts a high financial cost. Overall, the available evidence suggests that 15% of hospital expenditure and activity in OECD countries can be attributed to treating safety failures. Patient harm is felt in the broader economy through lost capacity and productivity of patients and carers. It is estimated that the aggregate costs amount to trillions of dollars each year. Most of the burden is associated with a few common adverse events. The most burdensome include healthcare-associated infections (HAI), venous
On-the-Radar-Issue-315.docx